A concept is the element of a proposition rather in the way that a word is the element of a sentence. Concepts are abstract in that they omit the differences of the things in their extension, treating them as if they were identical. Concepts are universal in that they apply equally to every thing in their extension.
Concepts are bearers of meaning as opposed to agents of meaning. A single concept can be expressed by any number of languages. The concept 'dog' can be expressed as 'Hund' in German, 'chien' in French, 'perro' in Spanish. The fact that concepts are in some sense language independent makes translation possible; words in various languages "mean the same" because they express one and the same concept.
The above usage of the word is quite modern, however. The definition below, (from Random House Unabridged Dictionary) is how the word was used up until not too many years ago:
1. a general notion or idea; conception. 2. an idea of something formed by mentally combining all its characteristics or particulars; a construct. 3. a directly conceived or intuited object of thought.
Conceptus specializes in the development of minimally invasive medical devices for reproductive medicine applications.
Any holder of Conceptus stock could have avoided trouble by noting the continued erosion of analysts' earnings estimates and the inability of the company to meet estimates.
In general, Conceptus appears to have an interesting technology and, even though it has very substantial competition, the company's microcatheter technology seems to have the edge, particularly in the diagnosis of tubal disorders.
Conceptus Inc. (Nasdaq:CPTS), developer of the Essure procedure, the first and only non-incisional permanent birth control method available, has been named to Deloitte's prestigious Technology Fast 500 Program.
Conceptus' CEO Mark Sieczkarek credits positive clinical data supporting the company's Essure System and improved patient reimbursement of the procedure with the company's 5,179 percent revenue growth from 2001-2005.
Conceptus, Inc. manufactures and markets the Essure Permanent Birth Control system, an innovative medical device and procedure designed to provide a non-incisional alternative to tubal ligation, which is currently the leading form of birth control worldwide.